Abbott Laboratories (NYSE:ABT)
| 107.07 Delayed Data As of Nov 25 |  +1.05 / +0.99%Today’s Change | 93.25 Today|||52-Week Range 142.60 | -23.92% Year-to-Date |
Latest ABT News | Press Releases
Today’s Trading
| Previous close | 106.02 |
| Today’s open | 106.67 |
| Day’s range | 106.60 - 107.34 |
| Volume | 2,558,110 |
| Average volume (3 months) | 5,347,792 |
| Market cap | $181.1B |
Data as of 1:00pm ET, 11/25/2022
Growth & Valuation
| Earnings growth (last year) | +57.26% |
| Earnings growth (this year) | +0.24% |
| Earnings growth (next 5 years) | +1.18% |
| Revenue growth (last year) | +24.47% |
| P/E ratio | 24.1 |
| Price/Sales | 5.85 |
| Price/Book | 5.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | +0.80 | +0.34% |
| BSXBoston Scientific Co... | +0.29 | +0.66% |
| DXCMDexcom Inc | -0.75 | -0.66% |
| BAXBaxter International... | -0.31 | -0.55% |
Data as of 1:00pm ET, 11/25/2022
Financials
| Next reporting date | January 25, 2023 |
| EPS forecast (this quarter) | $0.91 |
| Annual revenue (last year) | $43.1B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 16.35% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
